Dilated Cardiomyopathy
Gene: SCN5AEnsemblGeneIds (GRCh38): ENSG00000183873
EnsemblGeneIds (GRCh37): ENSG00000183873
OMIM: 600163, Gene2Phenotype
SCN5A is in 16 panels
1 review
Zornitza Stark (Victorian Clinical Genetics Services; Australian Genomics)
DEFINITIVE by ClinGen:
SCN5A was first reported in relation to autosomal dominant dilated cardiomyopathy (DCM) in 2005 (Olson et al., 2005, PMID: 15671429). Human genetic evidence supporting this gene-disease relationship includes case-level data and segregation data. Numerous variants (missense, frameshift, nonsense) have been reported in humans with isolated DCM (Olson et al., 2005, PMID: 15671429; Ge et al., 2008, PMID: 19808398; McNair et al., 2011, PMID: 21596231; Morales et al., 2011, PMID: 20458009; Grosselin-Badaroudine et al., 2012, PMID: 22675453; Laurent et al., 2012, PMID: 22766342; Mann et al., 2012, PMID: 22999724; Zakrzewska-Koperska et al., 2018, PMID: 29871609; Calloe et al., 2018, PMID: 29506689; Gigli et al., 2019, PMID: 31514951; Doisne et al., 2020, PMID: 31930659). This gene-disease association is supported by mouse models, a human iPS cell culture model, and expression studies. SCN5A mRNA levels were markedly decreased in heart tissues obtained from DCM patients (Kepenek et al., 2019, PMID: 31520233). The myosin heavy chain-Snail transgenic mice displayed a DCM phenotype with conduction block and marked reduction of SCN5A expression (Hesse, et al., 2007, PMID: 17512504). Heterozygous and homozygous knock-in mouse models harboring SCN5A p.D1275N displayed a DCM phenotype including intraventricular conduction block with marked reduction of cardiac sodium currents (Watanabe et al., 2011, PMID: 21824921). Furthermore, patient-derived human iPS cell-induced cardiomyocytes carrying SCN5A p.R219H showed reduced contraction, prolonged action potential duration, early afterdepolarization, and H+-leak currents (Moreau et al., 2018, PMID: 30218094).Created: 26 Mar 2021, 9:14 a.m. | Last Modified: 26 Mar 2021, 9:14 a.m.
Panel Version: 0.101
Mode of inheritance
MONOALLELIC, autosomal or pseudoautosomal, NOT imprinted
Phenotypes
Cardiomyopathy, dilated, 1E, MIM# 601154
Publications
Details
- Mode of Inheritance
- MONOALLELIC, autosomal or pseudoautosomal, NOT imprinted
- Sources
-
- Expert Review Green
- Victorian Clinical Genetics Services
- Phenotypes
-
- Cardiomyopathy, dilated, 1E, MIM# 601154
- OMIM
- 600163
- Clinvar variants
- Variants in SCN5A
- Penetrance
- None
- Publications
- Panels with this gene
-
- Stroke
- Brugada syndrome
- Additional findings_Adult
- Cardiomyopathy_Paediatric
- Incidentalome_PREGEN_DRAFT
- BabyScreen+ newborn screening
- Hydrops fetalis
- Transplant Co-Morbidity Superpanel
- Ventricular Fibrillation
- Short QT syndrome
- Long QT Syndrome
- Incidentalome
- Fetal anomalies
- Additional findings_Paediatric
- Dilated Cardiomyopathy
- Sick sinus syndrome
History Filter Activity
Entity classified by Genomics England curator
Zornitza Stark (Victorian Clinical Genetics Services; Australian Genomics)Gene: scn5a has been classified as Green List (High Evidence).
Set Phenotypes
Zornitza Stark (Victorian Clinical Genetics Services; Australian Genomics)Phenotypes for gene: SCN5A were changed from to Cardiomyopathy, dilated, 1E, MIM# 601154
Set publications
Zornitza Stark (Victorian Clinical Genetics Services; Australian Genomics)Publications for gene: SCN5A were set to
Set mode of inheritance
Zornitza Stark (Victorian Clinical Genetics Services; Australian Genomics)Mode of inheritance for gene: SCN5A was changed from Unknown to MONOALLELIC, autosomal or pseudoautosomal, NOT imprinted
Created, Added New Source, Set mode of inheritance
Zornitza Stark (Victorian Clinical Genetics Services; Australian Genomics)gene: SCN5A was added gene: SCN5A was added to Dilated cardiomyopathy_VCGS. Sources: Expert Review Green,Victorian Clinical Genetics Services Mode of inheritance for gene: SCN5A was set to Unknown